Le Lézard
Classified in: Health
Subject: AWD

2023 WOCNCB® Employer Recognition Winner is Northside Hospital Atlanta, Georgia


Recognized for Unyielding Support for WOCNCB® Certification

MILWAUKEE, June 5, 2023 /PRNewswire-PRWeb/ -- The Wound, Ostomy and Continence Nursing Certification Board (WOCNCB®) proudly welcomes Northside Hospital to the renowned list of Employer Recognition Award winners! The Northside Hospital health care system is one of Georgia's leading health care providers with five acute-care hospitals in Atlanta, Canton, Cumming, Duluth and Lawrenceville and more than 275 outpatient locations across the state. This award is given annually to honor an organization that has demonstrated exemplary support of the certification process in WOC nursing. Chosen from numerous candidates, Northside Hospital displays encouragement of advancement to all nurses within the organization seeking national specialty certification. The award will be presented in the WOCNCB booth #1200 at 1pm, June 5th at the Caesars Forum, Las Vegas, Nevada during WOCNext® 2023.

"This recognition validates the incredible commitment and dedicated focus our clinical teams have to provide quality care to our patients. We are proud of the many Northside Hospital nurses who achieve national specialty certifications, and we are honored to receive this award." - Janis Dubow, Chief Nursing Officer of Northside Hospital.

About WOCNCB®

A not-for-profit professional, international nursing organization certifying over 9,900 registered nurses who are specialists in the field of wound, ostomy, continence and foot care. WOCNCB® is the only certification for Wound, Ostomy, Continence and Foot Care nursing that is accredited by both the Accreditation Board for Specialty Nursing Certification (ABSNC) and National Commission for Certifying Agencies (NCCA) and is considered The Gold Standard for Certification®.

For more information, contact the WOCNCB® at (888) 496-2622, e-mail info@wocncb.org, or visit http://www.wocncb.org.

###

Media Contact

Lisa Obradovic, Wound, Ostomy and Continence Nursing Certification Board (WOCNCB®), 414-289-8721, lobradovic@wocncb.org

 

SOURCE Wound, Ostomy and Continence Nursing Certification Board (WOCNCB®)


These press releases may also interest you

at 17:20
Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Fillertm in Collaboration with Dr. Ian Lewis and Dr. Maen Husein's Labs
Biosenta Inc. ("Biosenta" or the "Company") is thrilled to announce a pivotal discovery led by Dr. Mehdi Mohammadi Ashani, a Postdoctoral Researcher under the mentorship of Dr. Ian Lewis and Dr. Maen Husein at the University of Calgary. Utilizing...

at 17:05
Quanterix CEO to Speak at Goldman Sachs Alzheimer's Disease Day
Quanterix Corporation , a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will speak on a panel at Goldman Sachs Alzheimer's Disease Day on Tuesday, October...

at 17:05
MEI Pharma Issues Statement Regarding Anson and Cable Car's Opportunistic Actions
MEI Pharma, Inc. (the "MEI" or "the Company") today issued the following statement in response to the consent solicitation initiated by a group led by Anson Advisors Inc. and Cable Car Capital LLC. The MEI Board of Directors and management team...

at 17:01
Neuroblastoma Market to Grow at a Substantial Growth Rate During the Forecast Period (2023-2032), Examines DelveInsight | Key Companies to Watch - Y-mAbs, Exelixis, Clarity, Eli Lilly, Innervate Radiopharmaceuticals, Adaptimmune
DelveInsight's Neuroblastoma Market Insights report includes a comprehensive understanding of current treatment practices, neuroblastoma emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to...

at 17:00
Medicenna Announces Results of Annual and Special Meeting of Shareholders
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") , a clinical-stage immuno-oncology company focused on the development of novel Superkines, today announced the voting results from the Company's annual and special meeting of shareholders...

at 16:59
BREAST CANCER AWARENESS MONTH: NEW CANCER RISK SURVEY REVEALS RISK FACTORS ARE WIDELY MISUNDERSTOOD
A new national survey from Myriad Genetics Inc., , a leader in genetic testing and precision medicine, revealed that breast density and family health history are two misunderstood breast cancer risk factors.  Experience the full interactive...

More news about Health...


News published on and distributed by: